Answers are grounded in this paper and cite their sources.
Uncovers TAFII31's role in enhancing p53-mediated transcriptional activation, suggesting therapeutic avenues.
The p53 protein activates transcription of a target gene by binding to a specific DNA response element and interacting with the transcriptional apparatus of RNA polymerase II. The amino-terminal domain of p53 interacts with a component of the TFIID basal transcription complex. The human TATA-binding-protein-associated factor TAFII31, a component of TFIID, has been identified as a critical protein required for p53-mediated transcriptional activation. TAFII31 and p53 proteins bind to each other via amino acid residues in the amino-terminal domain of p53 that are essential for transcription. Antibodies directed against TAFII31 protein inhibit p53-activated but not basal transcription in vitro. These results demonstrate that TAFII31 is a coactivator for the p53 protein.
No takes yet. Share an insight, caveat, or question.
Lu et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: